Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its p... Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Mehr anzeigen
NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Investor...
SAN DIEGO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Dermata Therapeutics, Inc. (Nasdaq: DRMA; DRMAW) (“Dermata” or the “Company”), a late-stage biotechnology company focused on the treatment of medical...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.1182 | 9.234375 | 1.28 | 1.48 | 1.182 | 151925 | 1.37192952 | CS |
| 4 | 0.3182 | 29.462962963 | 1.08 | 1.48 | 1.06 | 251316 | 1.30645722 | CS |
| 12 | 0.0282 | 2.05839416058 | 1.37 | 1.55 | 1 | 307914 | 1.33625071 | CS |
| 26 | -0.4018 | -22.3222222222 | 1.8 | 5 | 1 | 1400581 | 2.52238258 | CS |
| 52 | -5.6518 | -80.1673758865 | 7.05 | 8.655 | 1 | 766362 | 2.73505303 | CS |
| 156 | -353.8018 | -99.6063626126 | 355.2 | 588 | 1 | 904195 | 66.87623831 | CS |
| 260 | -1390.6018 | -99.8995545977 | 1392 | 1668 | 1 | 830825 | 117.69074295 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
